Skip to main content

Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats

  • 2015-06-17
  • Pediatric Research 78(4)
    • H. Izumi
    • M. Minegishi
    • Yohei Sato
    • Takashi Shimizu
    • K. Sekine
    • M. Takase

Abstract

Background: Bifidobacterium breve M-16V (M16V) is a probiotic bacterial strain with a long tradition of use in neonatal intensive care units in some countries. Previous study showed that the effects of M16V administration on gene expression were greater during the weaning period than in the neonatal period and were greater in the colon than in the small intestine and spleen, suggesting that M16V has anti-inflammatory effects. In this study, we evaluated the effects of inflammation during the weaning period and the effects of M16V on normal and inflammatory conditions.

Methods: From postnatal day (PD) 21 to 34, weanling rats were administered of 2.5 × 10(9) of M16V daily, and colitis was induced by administration of 2% dextran sulfate sodium from PD28 to 35. Colitis severity, immune function, and microbiota were investigated.

Results: Colitis caused a reduction in body weight gain, colon shortening, poor nutritional status, anemia, changes in blood and spleen lymphocyte populations, spleen T-cell malfunctions, and alterations in colon microbiota. M16V administration improved some but not all of the changes induced by colitis.

Conclusion: M16V could suppress inflammation and, therefore, can be considered a safe strain to use not only during the neonatal period but also the weaning period.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bifidobacterium breve M-16VImproved Body WeightBeneficial
Moderate
Bifidobacterium breve M-16VImproved Nutritional StatusBeneficial
Moderate
Bifidobacterium breve M-16VImproved Spleen T-Cell FunctionBeneficial
Moderate
Bifidobacterium breve M-16VReduced Colon ShorteningBeneficial
Moderate
Bifidobacterium breve M-16VReduced Prevalence of AnemiaBeneficial
Moderate
Bifidobacterium breve M-16VRestored Gut MicrobiotaBeneficial
Moderate
⬆ Back to top
Pillser
Supplement Research and Comparison Website: evidence-based information about supplements, their benefits, potential risks, and their efficacy.
Receive updates about our products, services, sales, and special offers. Unsubscribe anytime. See our Privacy Policy for details on how we handle your information.

Join Our Community

Use support@pillser.com to get in touch.